Positions

Principal Investigator On

  • Private Grant  awarded by MERCK & COMPANY, INC. 2012 - 2017
  • A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interforn Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects: Boceprevir, Interferon, Ribavirin to Treat HCV/HIV/Coinfected Subjects (BIRTH)  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2012 - 2014
  • Adult Clinical Trials Group Protocol #A5277 Supplemental Funds  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2012 - 2014
  • Adult Clinical Trials Group Protocol #A5303 Supplemental Funds  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2012 - 2014
  • A5272/A5280 Supplemental Funds from Adult Clinical Trials Group  awarded by Brigham and Women's Hospital 2012 - 2013
  • Virology Speciality Laboratory  awarded by Brigham and Women's Hospital 2012 - 2013
  • Adult Clinical Trials Group Protocol #A5280 Supplemental Funds  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2011 - 2013
  • ACTG Protocol A5269 The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naïve Genotype 1 Subjects with HIV Coinfection  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2011 - 2013
  • A5210.04-University of Alabama at Birmingham - VSL 54  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2010 - 2012
  • Adult Clinical Trials Group Protocol #A5272 Supplemental Funds  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2011 - 2012
  • BRS-ACURE-S-12-000054-002502 ACTG 5801  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2011 - 2012
  • Virology Specialty Laboratory  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2006 - 2012
  • Adult Clinical Trials Group Protocol#A5257 Supplemental Funds  awarded by SOCIAL & SCIENTIFIC SYSTEMS 2009 - 2011

    • Investigator On

  • Private Grant  awarded by GlaxoSmithKline 2014 - 2022
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by VIIV HEALTHCARE COMPANY 2016 - 2021
  • Private Grant  awarded by Gilead Sciences 2016 - 2020
  • Private Grant  awarded by GlaxoSmithKline 2012 - 2019
  • Private Grant  awarded by Gilead Sciences 2016 - 2019
  • AIDS Clinical Trials Group: Protocol Funds FTE Funding  awarded by Brigham and Women's Hospital 2014 - 2018
  • AIDS Clinical Trials Group: Protocol Funds  awarded by Brigham and Women's Hospital 2014 - 2018
  • Private Grant  awarded by Gilead Sciences 2014 - 2018
  • Private Grant  awarded by Gilead Sciences 2015 - 2018
  • Alabama Clinical Trials Unit (CTU)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2013 - 2017
  • Private Grant  awarded by ABBVIE INC 2013 - 2017
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2017
  • Private Grant  awarded by Gilead Sciences 2015 - 2017
  • Effect of Low Dose Methotrexate on Endothelial Function and Inflammation in HIV - A5314  awarded by Brigham and Women's Hospital 2013 - 2017
  • Private Grant  awarded by Gilead Sciences 2013 - 2017
  • Private Grant  awarded by Gilead Sciences 2013 - 2017
  • Private Grant  awarded by Gilead Sciences 2013 - 2016
  • Private Grant  awarded by Gilead Sciences 2013 - 2016
  • Private Grant  awarded by GlaxoSmithKline 2015
  • Private Grant  awarded by MERCK & COMPANY, INC. 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2013 - 2015
  • Private Grant  awarded by MERCK SHARP & DOHME CORP 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2014 - 2015
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2014 - 2015
  • Private Grant  awarded by Gilead Sciences 2010 - 2015
  • Private Grant  awarded by ABBVIE INC 2013 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2011 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2014
  • Private Grant  awarded by GlaxoSmithKline 2010 - 2014
  • Private Grant  awarded by Gilead Sciences 2010 - 2014
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Alabama - Clinical Trials Unit  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2007 - 2013
  • Private Grant  awarded by Gilead Sciences 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013
  • Private Grant  awarded by Gilead Sciences 2012 - 2013

    • Education And Training

  • Doctor of Medicine, University of Minnesota System : Twin Cities 1982
  • Dartmouth-Hitchcock Medical Center, Internship 1983
  • Dartmouth-Hitchcock Medical Center, Residency 1986
  • Massachusetts General Hospital, Postdoctoral Fellowship 1990
  • University of Colorado Health Sciences Center, Postdoctoral Fellowship 1987

    • Full Name

  • Victoria Johnson